Ignacio Faus
Chief Executive Officer chez NFL BIOSCIENCES
Profil
Ignacio Faus is currently the Chairman & Chief Executive Officer at NFL Biosciences SAS and an Advisor at DRI Capital, Inc. Previously, he served as the Chief Executive Officer at MOLOGEN AG from 2018 to 2019, Chief Executive Officer & Director at Genmedica Therapeutics SL, Chief Executive Officer at Palau Pharma SA in 2010, and Executive Director at Sage Healthcare Ltd.
He also worked as the Manager-Business Development at Noucor Health SA from 1993 to 2006.
Dr. Faus holds a doctorate degree from Indiana University, which he obtained in 1998, and an MBA from Kellogg School of Management, which he received in 1993.
Postes actifs de Ignacio Faus
| Sociétés | Poste | Début |
|---|---|---|
| NFL BIOSCIENCES | Chief Executive Officer | 19/05/2021 |
DRI Capital, Inc.
 DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Consultant / Advisor | - |
Anciens postes connus de Ignacio Faus
| Sociétés | Poste | Fin |
|---|---|---|
| MOLOGEN AG | Chief Executive Officer | 31/03/2019 |
Noucor Health SA
 Noucor Health SA Miscellaneous Commercial ServicesCommercial Services J. Uriach y Cia SA manufactures and markets pharmaceutical products. It offers consumer health products, including over-the-counter drugs, food supplements, personal health and wellbeing products, and nutricosmetic products. The company was founded by Juan Uriach Feliu in 1838 and is headquartered in Barcelona, Spain. | Corporate Officer/Principal | 01/11/2006 |
Sage Healthcare Ltd.
 Sage Healthcare Ltd. Miscellaneous Commercial ServicesCommercial Services Sage Healthcare Ltd. provides management consulting services to the healthcare industry. The firm's services include strategic analysis and development; mergers and acquisitions; business development, support, and planning; corporate partnering; licensing and venturing; technology and compound brokerage; valuations and value-enhancement planning; forecasting; risk assessment and due diligence; and commercial and technical assessment. The company was founded in 1995 and is headquartered in Great Shelford, GB. | Director/Board Member | - |
Palau Pharma SA
 Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Chief Executive Officer | - |
Genmedica Therapeutics SL
 Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Chief Executive Officer | - |
Formation de Ignacio Faus
| Indiana University | Doctorate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MOLOGEN AG | Commercial Services |
| NFL BIOSCIENCES | Health Technology |
| Entreprise privées | 5 |
|---|---|
DRI Capital, Inc.
DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Finance |
Noucor Health SA
Noucor Health SA Miscellaneous Commercial ServicesCommercial Services J. Uriach y Cia SA manufactures and markets pharmaceutical products. It offers consumer health products, including over-the-counter drugs, food supplements, personal health and wellbeing products, and nutricosmetic products. The company was founded by Juan Uriach Feliu in 1838 and is headquartered in Barcelona, Spain. | Commercial Services |
Genmedica Therapeutics SL
Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Health Technology |
Palau Pharma SA
Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Health Technology |
Sage Healthcare Ltd.
Sage Healthcare Ltd. Miscellaneous Commercial ServicesCommercial Services Sage Healthcare Ltd. provides management consulting services to the healthcare industry. The firm's services include strategic analysis and development; mergers and acquisitions; business development, support, and planning; corporate partnering; licensing and venturing; technology and compound brokerage; valuations and value-enhancement planning; forecasting; risk assessment and due diligence; and commercial and technical assessment. The company was founded in 1995 and is headquartered in Great Shelford, GB. | Commercial Services |
